(Q82851509)
Statements
An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients (English)
Vincenzo Callea
Antonio Cuneo
Stefania Ciolli
Nicola Di Renzo
Alfonso Piciocchi
Francesco Maura
Luca Laurenti
Nicola Cascavilla
Francesco Zallio
Sara Martinelli
Robin Foà
GIMEMA Chronic Lymphoproliferative Disorders Working Party